TY - JOUR
T1 - Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock
T2 - a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the Association for Acute Cardiovascular (ACVC) and the ESC Working Group on Cardiovascular Surgery
AU - Fraccaro, Chiara
AU - Karam, Nicole
AU - Möllmann, Helge
AU - Bleiziffer, Sabine
AU - Bonaros, Nikolaos
AU - Teles, Rui Campante
AU - Carrilho Ferreira, Pedro
AU - Chieffo, Alaide
AU - Czerny, Martin
AU - Donal, Erwan
AU - Dudek, Dariusz
AU - Dumonteil, Nicolas
AU - Esposito, Giovanni
AU - Fournier, Stephane
AU - Hassager, Christian
AU - Kim, Won-Keun
AU - Krychtiuk, Konstantin A
AU - Mehilli, Julinda
AU - Pręgowski, Jerzy
AU - Stefanini, Giulio G
AU - Ternacle, Julien
AU - Thiele, Holger
AU - Thielmann, Matthias
AU - Vincent, Flavien
AU - von Bardeleben, Ralph Stephan
AU - Tarantini, Giuseppe
PY - 2023/10/23
Y1 - 2023/10/23
N2 - Valvular heart disease (VHD) is one of the most frequent causes of heart failure (HF) and is associated with poor prognosis, particularly among patients with conservative management. The development and improvement of catheter-based VHD interventions have broadened the indications for transcatheter valve interventions from inoperable/high-risk patients to younger/lower-risk patients. Cardiogenic shock (CS) associated with severe VHD is a clinical condition with a very high risk of mortality for which surgical treatment is often deemed a prohibitive risk. Transcatheter valve interventions might be a promising alternative in this setting given that they are less invasive. However, supportive scientific evidence is scarce and often limited to small case series. Current guidelines on VHD do not contain specific recommendations on how to manage patients with both VHD and CS. The purpose of this clinical consensus statement, developed by a group of international experts invited by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Scientific Documents and Initiatives Committee, is to perform a review of the available scientific evidence on the management of CS associated with left-sided VHD and to provide a rationale and practical approach for the application of transcatheter valve interventions in this specific clinical setting.
AB - Valvular heart disease (VHD) is one of the most frequent causes of heart failure (HF) and is associated with poor prognosis, particularly among patients with conservative management. The development and improvement of catheter-based VHD interventions have broadened the indications for transcatheter valve interventions from inoperable/high-risk patients to younger/lower-risk patients. Cardiogenic shock (CS) associated with severe VHD is a clinical condition with a very high risk of mortality for which surgical treatment is often deemed a prohibitive risk. Transcatheter valve interventions might be a promising alternative in this setting given that they are less invasive. However, supportive scientific evidence is scarce and often limited to small case series. Current guidelines on VHD do not contain specific recommendations on how to manage patients with both VHD and CS. The purpose of this clinical consensus statement, developed by a group of international experts invited by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Scientific Documents and Initiatives Committee, is to perform a review of the available scientific evidence on the management of CS associated with left-sided VHD and to provide a rationale and practical approach for the application of transcatheter valve interventions in this specific clinical setting.
KW - TAVI
KW - acute heart failure
KW - aortic regurgitation
KW - aortic stenosis
KW - mitral regurgitation
KW - mitral stenosis
U2 - 10.4244/EIJ-D-23-00473
DO - 10.4244/EIJ-D-23-00473
M3 - Article
C2 - 37624587
SN - 1774-024X
VL - 19
SP - 634
EP - 651
JO - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
JF - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
IS - 8
ER -